| Year |
Citation |
Score |
| 2020 |
Zhou H, Hu R, Tang O, Hu C, Tang L, Chang K, Shen Q, Wu J, Zou B, Xiao B, Boxerman J, Chen W, Huang RY, Yang L, Bai HX, et al. Automatic Machine Learning to Differentiate Pediatric Posterior Fossa Tumors on Routine MR Imaging. Ajnr. American Journal of Neuroradiology. 41: 1279-1285. PMID 32661052 DOI: 10.3174/Ajnr.A6621 |
0.331 |
|
| 2020 |
Mellinghoff IK, Ellingson BM, Touat M, Maher E, De La Fuente MI, Holdhoff M, Cote GM, Burris H, Janku F, Young RJ, Huang R, Jiang L, Choe S, Fan B, Yen K, et al. Ivosidenib in Isocitrate Dehydrogenase 1Mutated Advanced Glioma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1903327. PMID 32530764 DOI: 10.1200/Jco.19.03327 |
0.351 |
|
| 2020 |
Wen PY, Weller M, Lee EQ, Alexander BA, Barnholtz-Sloan JS, Barthel FP, Batchelor TT, Bindra RS, Chang SM, Chiocca EA, Cloughesy TF, DeGroot JF, Galanis E, Gilbert MR, Hegi ME, ... ... Huang RY, et al. Glioblastoma in Adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) Consensus Review on Current Management and Future Directions. Neuro-Oncology. PMID 32328653 DOI: 10.1093/Neuonc/Noaa106 |
0.305 |
|
| 2020 |
Huang RY, Young RJ, Ellingson BM, Veeraraghavan H, Wang W, Tixier F, Um H, Nawaz R, Luks T, Kim J, Gerstner ER, Schiff D, Peters KB, Mellinghoff IK, Chang S, et al. Volumetric Analysis of IDH-Mutant Lower-Grade Glioma: A Natural History Study of Tumor Growth Rates Before and After Treatment. Neuro-Oncology. PMID 32328652 DOI: 10.1093/Neuonc/Noaa105 |
0.323 |
|
| 2020 |
Touat M, Li YY, Boynton AN, Spurr LF, Iorgulescu JB, Bohrson CL, Cortes-Ciriano I, Birzu C, Geduldig JE, Pelton K, Lim-Fat MJ, Pal S, Ferrer-Luna R, Ramkissoon SH, Dubois F, ... ... Huang RY, et al. Mechanisms and therapeutic implications of hypermutation in gliomas. Nature. 580: 517-523. PMID 32322066 DOI: 10.1038/S41586-020-2209-9 |
0.31 |
|
| 2020 |
Peng J, Zhou H, Tang O, Chang K, Wang P, Zeng X, Shen Q, Wu J, Xiao Y, Patel SH, Hu C, Jin K, Xiao B, Boxerman J, Gao X, ... ... Huang RY, et al. Evaluation of RAPNO criteria in medulloblastoma and other leptomeningeal seeding tumors using MRI and clinical data. Neuro-Oncology. PMID 32215549 DOI: 10.1093/Neuonc/Noaa072 |
0.344 |
|
| 2020 |
Kaufmann TJ, Smits M, Boxerman J, Huang R, Barboriak DP, Weller M, Chung C, Tsien C, Brown PD, Shankar L, Galanis E, Gerstner E, van den Bent MJ, Burns TC, Parney IF, et al. Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases (BTIP-BM). Neuro-Oncology. PMID 32048719 DOI: 10.1093/Neuonc/Noaa030 |
0.33 |
|
| 2020 |
Huang RY, Lin A. Whole-Brain MR Spectroscopy Imaging of Brain Tumor Metabolites. Radiology. 192607. PMID 31910073 DOI: 10.1148/Radiol.2020192607 |
0.306 |
|
| 2020 |
Ly KI, Wen PY, Huang RY. Imaging of Central Nervous System Tumors Based on the 2016 World Health Organization Classification. Neurologic Clinics. 38: 95-113. PMID 31761063 DOI: 10.1016/J.Ncl.2019.08.004 |
0.348 |
|
| 2020 |
Ellingson BM, Huang RY, Villanueva-Meyer J, Lim-Fat MJ, George E, Iorgulescu B, Young G, Raymond C, Oughourlian T, Schlossman J, Gleason T, Oberheim Bush NA, Wen PY, Cloughesy TF, Chang SM, et al. Estimated clinical efficacy and radiographic response characteristics of PD1 inhibition in newly diagnosed and recurrent glioblastoma in clinical practice: A report from the iRANO Working Group. Journal of Clinical Oncology. 38: 2521-2521. DOI: 10.1200/Jco.2020.38.15_Suppl.2521 |
0.362 |
|
| 2019 |
Peng C, Ho J, Bai HX, Huang Y, Huang RY, Yang L. Adjuvant radiotherapy and chemotherapy in early-stage diffuse large B cell lymphoma of head and neck with extranodal involvement. Hematology (Amsterdam, Netherlands). 24: 268-275. PMID 31793408 DOI: 10.1080/16078454.2019.1565148 |
0.304 |
|
| 2019 |
Miskin N, Unadkat P, Carlton ME, Golby AJ, Young GS, Huang RY. Frequency and Evolution of New Postoperative Enhancement on 3 Tesla Intraoperative and Early Postoperative Magnetic Resonance Imaging. Neurosurgery. PMID 31584071 DOI: 10.1093/Neuros/Nyz398 |
0.321 |
|
| 2019 |
Zhou H, Bai HX, Chan L, Zhang PJ, Karakousis G, Huang R, Xiao B, Yang L. Survival benefit of adjuvant radiotherapy in elderly patients with WHO grade Ⅲ meningioma. World Neurosurgery. PMID 31356979 DOI: 10.1016/J.Wneu.2019.07.140 |
0.322 |
|
| 2019 |
Chang K, Beers AL, Bai HX, Brown JM, Ly KI, Li X, Senders JT, Kavouridis VK, Boaro A, Su C, Bi WL, Rapalino O, Liao W, Shen Q, Zhou H, ... ... Huang RY, et al. Automatic assessment of glioma burden: A deep learning algorithm for fully automated volumetric and bi-dimensional measurement. Neuro-Oncology. PMID 31190077 DOI: 10.1093/Neuonc/Noz106 |
0.31 |
|
| 2019 |
Bi WL, Hosny A, Schabath MB, Giger ML, Birkbak NJ, Mehrtash A, Allison T, Arnaout O, Abbosh C, Dunn IF, Mak RH, Tamimi RM, Tempany CM, Swanton C, Hoffmann U, ... ... Huang RY, et al. Artificial intelligence in cancer imaging: Clinical challenges and applications. Ca: a Cancer Journal For Clinicians. PMID 30720861 DOI: 10.3322/Caac.21552 |
0.341 |
|
| 2019 |
Huang RY, Bi WL, Griffith B, Kaufmann TJ, la Fougère C, Schmidt NO, Tonn JC, Vogelbaum MA, Wen PY, Aldape K, Nassiri F, Zadeh G, Dunn IF. Imaging and diagnostic advances for intracranial meningiomas. Neuro-Oncology. 21: i44-i61. PMID 30649491 DOI: 10.1093/Neuonc/Noy143 |
0.365 |
|
| 2019 |
Chawla SP, Chua VS, Gordon EM, Moradkhani A, Kim K, Quon D, Wong S, Sumner R, Mac V, Huang R, Wang K, Kim J, Kim B, McGinn AN, Park CH, et al. Phase I study to evaluate the safety and efficacy of rivoceranib (apatinib) and nivolumab in patients with unresectable or metastatic cancer. Journal of Clinical Oncology. 37: 18-18. DOI: 10.1200/Jco.2019.37.8_Suppl.18 |
0.325 |
|
| 2019 |
Touat M, Li Y, Boynton A, Spurr L, Iorgulescu B, Birzu C, Pal S, Ferrer-Luna R, Geduldig J, Bellamy C, Younan N, Baldini C, Verreault M, Guillerm E, Ammari S, ... ... Huang R, et al. DRES-08. CLINICAL SIGNIFICANCE OF HYPERMUTATION IN GLIOMAS Neuro-Oncology. 21: vi73-vi73. DOI: 10.1093/Neuonc/Noz175.296 |
0.35 |
|
| 2019 |
Touat M, Li Y, Boynton A, Spurr L, Iorglescu B, Geduldig J, Birzu C, Lim Fat M, Santagata S, Coulet F, Beuvon F, Mokhtari K, Giry M, Block S, Guillerm E, ... ... Huang R, et al. OS9.1 Clinical significance of hypermutation in gliomas Neuro-Oncology. 21: iii18-iii18. DOI: 10.1093/Neuonc/Noz126.059 |
0.346 |
|
| 2018 |
Ismail M, Hill V, Statsevych V, Huang R, Prasanna P, Correa R, Singh G, Bera K, Beig N, Thawani R, Madabhushi A, Aahluwalia M, Tiwari P. Shape Features of the Lesion Habitat to Differentiate Brain Tumor Progression from Pseudoprogression on Routine Multiparametric MRI: A Multisite Study. Ajnr. American Journal of Neuroradiology. PMID 30385468 DOI: 10.3174/Ajnr.A5858 |
0.348 |
|
| 2018 |
George E, Kijewski MF, Dubey S, Belanger AP, Reardon DA, Wen PY, Kesari S, Horky L, Park MA, Huang RY. Voxel-Wise Analysis of Fluoroethyltyrosine PET and MRI in the Assessment of Recurrent Glioblastoma During Antiangiogenic Therapy. Ajr. American Journal of Roentgenology. 1-6. PMID 30332289 DOI: 10.2214/Ajr.18.19988 |
0.33 |
|
| 2018 |
Wu J, Kim C, Bai HX, Tang L, Wang Y, Li X, Zhang Z, Karakousis G, Huang R, Zhang PJ, Xiao B, Yang L. Comparison of adjuvant radiation therapy alone and chemotherapy alone for low-grade gliomas without surgical resection. World Neurosurgery. PMID 30261385 DOI: 10.1016/J.Wneu.2018.09.109 |
0.314 |
|
| 2018 |
Sridharan V, Rahman RM, Huang RY, Chau NG, Lorch JH, Uppaluri R, Haddad RI, Hanna GJ, Schoenfeld JD. Radiologic predictors of immune checkpoint inhibitor response in advanced head and neck squamous cell carcinoma. Oral Oncology. 85: 29-34. PMID 30220316 DOI: 10.1016/J.Oraloncology.2018.08.005 |
0.359 |
|
| 2018 |
Kurz SC, Cabrera LP, Hastie D, Huang R, Unadkat P, Rinne M, Nayak L, Lee EQ, Reardon DA, Wen PY. PD-1 inhibition has only limited clinical benefit in patients with recurrent high-grade glioma. Neurology. PMID 30171077 DOI: 10.1212/Wnl.0000000000006283 |
0.301 |
|
| 2018 |
Huang RY, Unadkat P, Linda Bi W, George E, Preusser M, McCracken DJ, Keen JR, Read WL, Olson JJ, Seystahl K, Le Rhun E, Roelcke U, Koeppen S, Furtner J, Weller M, et al. Response Assessment of Meningioma: 1D, 2D and Volumetric Criteria for Treatment Response and Tumor Progression. Neuro-Oncology. PMID 30085283 DOI: 10.1093/Neuonc/Noy126 |
0.353 |
|
| 2018 |
Huang Y, Chan L, Bai HX, Li X, Zhang Z, Wang Y, Cao Y, Karakousis G, Huang R, Xiao B, Zhang PJ, Yang L. Assessment of care pattern and outcome in hemangioblastoma. Scientific Reports. 8: 11144. PMID 30042517 DOI: 10.1038/S41598-018-29047-9 |
0.319 |
|
| 2018 |
Zou Y, Neale N, Sun J, Yang M, Bai HX, Tang L, Zhang Z, Landi A, Wang Y, Huang RY, Zhang PJ, Li X, Xiao B, Yang L. Prognostic factors in clival chordomas: an integrated analysis of 347 patients. World Neurosurgery. PMID 29969746 DOI: 10.1016/J.Wneu.2018.06.194 |
0.308 |
|
| 2018 |
Ellingson BM, Abrey LE, Nelson SJ, Kaufmann TJ, Garcia J, Chinot O, Saran F, Nishikawa R, Henriksson R, Mason WP, Wick W, Butowski N, Ligon KL, Gerstner ER, Colman H, ... ... Huang RY, et al. Validation of post-operative residual contrast enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma. Neuro-Oncology. PMID 29660006 DOI: 10.1093/Neuonc/Noy053 |
0.367 |
|
| 2018 |
Nandu H, Wen PY, Huang RY. Imaging in neuro-oncology. Therapeutic Advances in Neurological Disorders. 11: 1756286418759865. PMID 29511385 DOI: 10.1177/1756286418759865 |
0.367 |
|
| 2018 |
Zhou M, Zhou Y, Liao H, Rowland BC, Kong X, Arvold ND, Reardon DA, Wen PY, Lin AP, Huang RY. Diagnostic Accuracy of 2-Hydroxyglutarate Magnetic Resonance Spectroscopy in Newly-Diagnosed Brain Mass and Suspected Recurrent Gliomas. Neuro-Oncology. PMID 29438510 DOI: 10.1093/Neuonc/Noy022 |
0.313 |
|
| 2018 |
Wu J, Neale N, Huang Y, Bai HX, Li X, Zhang Z, Karakousis G, Huang R, Zhang PJ, Tang L, Xiao B, Yang L. Comparison of adjuvant radiation therapy alone and chemotherapy alone in surgically resected low-grade gliomas: survival analyses of 2253 cases from the National Cancer Data Base. World Neurosurgery. PMID 29409888 DOI: 10.1016/J.Wneu.2018.01.163 |
0.323 |
|
| 2017 |
Chang K, Bai HX, Zhou H, Su C, Bi WL, Agbodza E, Kavouridis VK, Senders JT, Boaro A, Beers AL, Zhang B, Capellini A, Liao W, Shen Q, Li X, ... ... Huang RY, et al. Residual Convolutional Neural Network for Determination of IDH Status in Low- and High-grade Gliomas from MR Imaging. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29167275 DOI: 10.1158/1078-0432.Ccr-17-2236 |
0.326 |
|
| 2017 |
Coroller TP, Bi WL, Huynh E, Abedalthagafi M, Aizer AA, Greenwald NF, Parmar C, Narayan V, Wu WW, Miranda de Moura S, Gupta S, Beroukhim R, Wen PY, Al-Mefty O, Dunn IF, ... ... Huang RY, et al. Radiographic prediction of meningioma grade by semantic and radiomic features. Plos One. 12: e0187908. PMID 29145421 DOI: 10.1371/Journal.Pone.0187908 |
0.338 |
|
| 2017 |
Ellingson BM, Gerstner E, Smits M, Huang RY, Colen RR, Abrey LE, Aftab DT, Schwab GM, Hessel C, Harris RJ, Chakhoyan A, Gahrmann R, Pope WB, Leu K, Raymond C, et al. Diffusion MRI phenotypes predict overall survival benefitfrom anti-VEGF monotherapy in recurrent glioblastoma:Converging evidence from phase II trials. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28655794 DOI: 10.1158/1078-0432.Ccr-16-2844 |
0.358 |
|
| 2017 |
Mullen KM, Huang RY. An Update on the Approach to the Imaging of Brain Tumors. Current Neurology and Neuroscience Reports. 17: 53. PMID 28516376 DOI: 10.1007/S11910-017-0760-Z |
0.354 |
|
| 2017 |
Grossmann P, Narayan V, Chang K, Rahman R, Abrey L, Reardon DA, Schwartz LH, Wen PY, Alexander BM, Huang R, Aerts HJWL. Quantitative Imaging Biomarkers for Risk Stratification of Patients with Recurrent Glioblastoma Treated with Bevacizumab. Neuro-Oncology. PMID 28499022 DOI: 10.1093/Neuonc/Nox092 |
0.364 |
|
| 2017 |
Huang R. Response assessment in high-grade glioma: tumor volume as endpoint. Neuro-Oncology. PMID 28379518 DOI: 10.1093/Neuonc/Nox035 |
0.33 |
|
| 2017 |
Isamail M, Prasanna P, Huang R, Singh G, Thawani R, Madabhushi A, Ahluwalia M, Tiwari P. NIMG-80. SHAPE ATTRIBUTES OF ENHANCING LESION BOUNDARIES CAN DIFFERENTIATE TUMOR RECURRENCE FROM PSEUDO-PROGRESSION ON ROUTINE BRAIN MRI SCANS: PRELIMINARY FINDINGS Neuro-Oncology. 19: vi160-vi160. DOI: 10.1093/Neuonc/Nox168.651 |
0.326 |
|
| 2017 |
Zhou H, Huang R, Karakousis G, Zhang P, Chan L, Bai H, Xiao B, Yang L. MNGI-10. SURVIVAL BENEFIT ASSOCIATED WITH ADJUVANT RADIOTHERAPY IN ELDERLY PATIENTS WITH WHO GRADE lll MENINGIOMA Neuro-Oncology. 19. DOI: 10.1093/Neuonc/Nox168.548 |
0.312 |
|
| 2016 |
Grossmann P, Narayan V, Huang R, Aerts H. TU-D-207B-07: Radiomic Response Assessment for Recurrent Glioblastoma Treated with Bevacizumab in the BRAIN Trial. Medical Physics. 43: 3751-3752. PMID 28048647 DOI: 10.1118/1.4957515 |
0.319 |
|
| 2016 |
Coroller T, Bi W, Abedalthagafi M, Aizer A, Wu W, Greenwald N, Beroukhim R, Al-Mefty O, Santagata S, Dunn I, Alexander B, Huang R, Aerts H. SU-D-207B-02: Early Grade Classification in Meningioma Patients Combining Radiomics and Semantics Data. Medical Physics. 43: 3348-3349. PMID 28048264 DOI: 10.1118/1.4955670 |
0.355 |
|
| 2016 |
Huang RY, Wen PY. Response Assessment in Neuro-Oncology Criteria and Clinical Endpoints. Magnetic Resonance Imaging Clinics of North America. 24: 705-718. PMID 27742111 DOI: 10.1016/J.Mric.2016.06.003 |
0.382 |
|
| 2016 |
Zhang B, Chang K, Ramkissoon S, Tanguturi S, Bi WL, Reardon DA, Ligon KL, Alexander BM, Wen PY, Huang RY. Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas. Neuro-Oncology. PMID 27353503 DOI: 10.1093/Neuonc/Now121 |
0.319 |
|
| 2016 |
Chang K, Zhang B, Guo X, Zong M, Rahman R, Sanchez D, Winder N, Reardon DA, Zhao B, Wen PY, Huang RY. Multimodal imaging patterns predict survival in recurrent glioblastoma patients treated with bevacizumab. Neuro-Oncology. PMID 27257279 DOI: 10.1093/Neuonc/Now086 |
0.324 |
|
| 2016 |
Diamandis P, Ferrer-Luna R, Huang RY, Folkerth RD, Ligon AH, Wen PY, Beroukhim R, Ligon KL, Ramkissoon SH. Case Report: Next generation sequencing identifies a NAB2-STAT6 fusion in Glioblastoma. Diagnostic Pathology. 11: 13. PMID 26817999 DOI: 10.1186/S13000-016-0455-9 |
0.348 |
|
| 2016 |
Zhang B, Chang K, Ramkissoon S, Tanguturi SK, Bi WL, Reardon DA, Ligon KL, Alexander BM, Wen PY, Huang RY. Predicting isocitrate dehydrogenase genotype in malignant glioma with multimodality imaging markers. Journal of Clinical Oncology. 34: 2009-2009. DOI: 10.1200/Jco.2016.34.15_Suppl.2009 |
0.352 |
|
| 2015 |
Okada H, Weller M, Huang R, Finocchiaro G, Gilbert MR, Wick W, Ellingson BM, Hashimoto N, Pollack IF, Brandes AA, Franceschi E, Herold-Mende C, Nayak L, Panigrahy A, Pope WB, et al. Immunotherapy response assessment in neuro-oncology: a report of the RANO working group. The Lancet. Oncology. 16: e534-42. PMID 26545842 DOI: 10.1016/S1470-2045(15)00088-1 |
0.377 |
|
| 2015 |
Huang RY, Rahman R, Ballman KV, Felten S, Anderson K, Ellingson BM, Nayak L, Lee EQ, Abrey LE, Galanis E, Reardon DA, Pope WB, Cloughesy TF, Wen PY. The Impact of T2/FLAIR Evaluation per RANO Criteria on Response Assessment of Recurrent Glioblastoma Patients Treated with Bevacizumab. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26490307 DOI: 10.1158/1078-0432.Ccr-14-3040 |
0.332 |
|
| 2015 |
Huang RY, Neagu MR, Reardon DA, Wen PY. Pitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy - detecting illusive disease, defining response. Frontiers in Neurology. 6: 33. PMID 25755649 DOI: 10.3389/Fneur.2015.00033 |
0.411 |
|
| 2015 |
Neagu MR, Huang RY, Reardon DA, Wen PY. How treatment monitoring is influencing treatment decisions in glioblastomas. Current Treatment Options in Neurology. 17: 343. PMID 25749847 DOI: 10.1007/S11940-015-0343-8 |
0.385 |
|
| 2015 |
Okada H, Weller M, Huang R, Finocchiaro G, Gilbert M, Wick W, Ellingson B, Hashimoto N, Pollack I, Brandes A, Franceschi E, Herold-Mende C, Nayak L, Panigrahy A, Pope W, et al. NIMG-56IMMUNOTHERAPY RESPONSE ASSESSMENT IN NEURO-ONCOLOGY (iRANO): A REPORT OF THE RANO WORKING GROUP Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov225.56 |
0.394 |
|
| 2014 |
Rahman R, Hempfling K, Norden AD, Reardon DA, Nayak L, Rinne ML, Beroukhim R, Doherty L, Ruland S, Rai A, Rifenburg J, LaFrankie D, Alexander BM, Huang RY, Wen PY, et al. Retrospective study of carmustine or lomustine with bevacizumab in recurrent glioblastoma patients who have failed prior bevacizumab. Neuro-Oncology. 16: 1523-9. PMID 24958095 DOI: 10.1093/Neuonc/Nou118 |
0.318 |
|
| 2014 |
Rahman R, Hamdan A, Zweifler R, Jiang H, Norden AD, Reardon DA, Mukundan S, Wen PY, Huang RY. Histogram analysis of apparent diffusion coefficient within enhancing and nonenhancing tumor volumes in recurrent glioblastoma patients treated with bevacizumab. Journal of Neuro-Oncology. 119: 149-58. PMID 24805151 DOI: 10.1200/Jco.2014.32.15_Suppl.2058 |
0.357 |
|
| 2014 |
Huang RY, Rahman R, Pope WB, Ellingson BM, Anderson SK, Felten SJ, Ballman KV, Wu W, Nayak L, Lee EQ, Abrey LE, Galanis E, Reardon DA, Cloughesy TF, Wen PY. Validation of rano criteria: Contribution of T2/FLAIR assessment in patients with recurrent glioblastoma treated with bevacizumab. Journal of Clinical Oncology. 32: 2007-2007. DOI: 10.1200/Jco.2014.32.15_Suppl.2007 |
0.362 |
|
| 2014 |
Huang R, Rahman R, Pope W, Ellingson B, Ballman K, Felton S, Anderson SK, Nayak L, Lee E, Abrey L, Galanis E, Reardon D, Cloughesy T, Wen P. NI-36 * VALIDATION OF RANO CRITERIA: CONTRIBUTION OF T2/FLAIR ASSESSMENT IN PATIENTS WITH RECURRENT GLIOBLASTOMA TREATED WITH BEVACIZUMAB Neuro-Oncology. 16: v145-v146. DOI: 10.1093/Neuonc/Nou264.34 |
0.346 |
|
| 2013 |
Abd-El-Barr MM, Saleh E, Huang RY, Golby AJ. Effect of disease and recovery on functional anatomy in brain tumor patients: insights from functional MRI and diffusion tensor imaging. Imaging in Medicine. 5: 333-346. PMID 24660024 DOI: 10.2217/Iim.13.40 |
0.339 |
|
| 2013 |
Chen C, Huang R, MacLean A, Muzikansky A, Mukundan S, Wen PY, Norden AD. Recurrent high-grade glioma treated with bevacizumab: Prognostic value of MGMT methylation, EGFR status and pretreatment MRI in determining response and survival Journal of Neuro-Oncology. 115: 267-276. PMID 23974656 DOI: 10.1007/S11060-013-1225-0 |
0.386 |
|
| 2013 |
Huang RY, Rahman R, Hamdan A, Kane C, Chen C, Norden AD, Reardon DA, Mukundun S, Wen PY. Recurrent glioblastoma: volumetric assessment and stratification of patient survival with early posttreatment magnetic resonance imaging in patients treated with bevacizumab. Cancer. 119: 3479-88. PMID 23821555 DOI: 10.1002/Cncr.28210 |
0.377 |
|
| 2013 |
Huang R, Rahman R, Hamdan A, Kane C, Chen C, Norden AD, Reardon DA, Mukundan S, Wen PY. Recurrent glioblastoma: Stratification of patient survival using tumor volume before and after antiangiogenic treatment. Journal of Clinical Oncology. 31: 2075-2075. DOI: 10.1200/Jco.2013.31.15_Suppl.2075 |
0.403 |
|
| 2012 |
Zhu Y, Young GS, Xue Z, Huang RY, You H, Setayesh K, Hatabu H, Cao F, Wong ST. Semi-automatic segmentation software for quantitative clinical brain glioblastoma evaluation. Academic Radiology. 19: 977-85. PMID 22591720 DOI: 10.1016/J.Acra.2012.03.026 |
0.343 |
|
| 2005 |
Shi W, Zhan C, Ignatov A, Manjasetty BA, Marinkovic N, Sullivan M, Huang R, Chance MR. Metalloproteomics: high-throughput structural and functional annotation of proteins in structural genomics. Structure (London, England : 1993). 13: 1473-86. PMID 16216579 DOI: 10.1016/J.Str.2005.07.014 |
0.456 |
|
| 2003 |
Huang RY, Miller LM, Carlson CS, Chance MR. In situ chemistry of osteoporosis revealed by synchrotron infrared microspectroscopy. Bone. 33: 514-21. PMID 14555254 DOI: 10.1016/S8756-3282(03)00233-3 |
0.446 |
|
| 2003 |
Huang RY, Boulton SJ, Vidal M, Almo SC, Bresnick AR, Chance MR. High-throughput expression, purification, and characterization of recombinant Caenorhabditis elegans proteins. Biochemical and Biophysical Research Communications. 307: 928-34. PMID 12878200 DOI: 10.1016/S0006-291X(03)01265-8 |
0.465 |
|
| 2003 |
Reboul J, Vaglio P, Rual JF, Lamesch P, Martinez M, Armstrong CM, Li S, Jacotot L, Bertin N, Janky R, Moore T, Hudson JR, Hartley JL, Brasch MA, Vandenhaute J, ... ... Huang R, et al. C. elegans ORFeome version 1.1: experimental verification of the genome annotation and resource for proteome-scale protein expression. Nature Genetics. 34: 35-41. PMID 12679813 DOI: 10.1038/Ng1140 |
0.464 |
|
| 2002 |
Marinkovic NS, Huang R, Bromberg P, Sullivan M, Toomey J, Miller LM, Sperber E, Moshe S, Jones KW, Chouparova E, Lappi S, Franzen S, Chance MR. Center for Synchrotron Biosciences' U2B beamline: an international resource for biological infrared spectroscopy. Journal of Synchrotron Radiation. 9: 189-97. PMID 12091724 DOI: 10.1107/S0909049502008543 |
0.463 |
|
| 2002 |
Chance MR, Bresnick AR, Burley SK, Jiang JS, Lima CD, Sali A, Almo SC, Bonanno JB, Buglino JA, Boulton S, Chen H, Eswar N, He G, Huang R, Ilyin V, et al. Structural genomics: a pipeline for providing structures for the biologist. Protein Science : a Publication of the Protein Society. 11: 723-38. PMID 11910018 DOI: 10.1110/Ps.4570102 |
0.463 |
|
| 2002 |
Huang RY, Miller LM, Carlson CS, Chance MR. Characterization of bone mineral composition in the proximal tibia of cynomolgus monkeys: effect of ovariectomy and nandrolone decanoate treatment. Bone. 30: 492-7. PMID 11882463 DOI: 10.1016/S8756-3282(01)00691-3 |
0.454 |
|
| 1999 |
Miller LM, Huang R, Chance MR, Carlson CS. Applications of fluorescence-assisted infrared microspectroscopy to the study of osteoporosis Synchrotron Radiation News. 12: 21-27. DOI: 10.1080/08940889908260970 |
0.428 |
|
| Show low-probability matches. |